Hepatocellular Carcinoma in Patients with a Sustained Response to Anti-Hepatitis C Therapy
Roberta D’Ambrosio(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), M. Colombo(University of Milan), C. Della Corte(University of Milan)
Cited by 70
Related Papers
Global patterns of hepatocellular carcinoma management from diagnosis to death: the <scp>BRIDGE</scp> Study
|Liver International|2015|1.3k
A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis
|Hepatology|2012|404
High rates of 30-day mortality in patients with cirrhosis and COVID-19
|Journal of Hepatology|2020|392
Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores
|Journal of Hepatology|2020|361
Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication
|Journal of Hepatology|2016|273